Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKGY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,809
Award facts
- Contract value 100% obligated
- $10,809.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $10,809.06 under a firm fixed-price contract type. The delivery order was awarded on December 31, 2025, with an ultimate completion date of January 2, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order issued against an existing contract vehicle. Dupixent (dupilumab) is a biologic therapeutic commonly prescribed for moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions, making this order consistent with federal healthcare supply requirements for military and veteran medical programs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply specialty medications, brand-name pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains, with delivery orders consistently awarded through open competition at firm fixed prices.
Quick answers
Who was awarded contract SPE2DR26FAKGY?
SPE2DR26FAKGY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FAKGY worth?
The government has obligated $10,809 on SPE2DR26FAKGY.
Is contract SPE2DR26FAKGY an order under another contract?
Yes. SPE2DR26FAKGY is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKGY competed?
The extent of competition for SPE2DR26FAKGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award